The Chinese government-sponsored Covid 19 vaccine (Corona virus vaccine) has also been successfully tested in the second phase of medical trials, namely Phase II clinical trials.
According to a report published in the latest issue of the Journal of the American Medical Association (JAMA), the vaccine is administered by the Chinese Academy of Sciences, the Wuhan Institute of Virology, the Wuhan Institute of Biological Products and China. Developed jointly by the National Biotech Group.
This vaccine is different from other coronavirus vaccines in that it uses ineffective novel corona viruses as vaccines. This is a relatively recent form of vaccine that is considered to be much better than conventional vaccines.
A total of 320 healthy volunteers between the ages of 18 and 59 were recruited for the first phase (Phase 1) and second phase (Phase 2) medical trials.
The majority of volunteers who received the vaccine developed immunity to the corona virus, while the negative or harmful effects of the vaccine were rarely observed.
Although this success is significant, experts involved in the study have warned that until the third phase of the vaccine's medical trials (Phase III clinical trials) are successful, there is little confidence in its effectiveness. It would be premature to say.
It should be noted that in Phase III clinical trials, any new drug is tested on 1000 to 3000 people and after evaluating its efficacy, side effects and other aspects, if the drug is really effective, then it can be used. Approved for widespread use.
